No Data
No Data
touchstone international medical science co., ltd. (688013.SH) plans to distribute 5 yuan for every 10 shares at the half-year, with ex-rights and ex-dividends on October 11th.
touchstone international medical science co., ltd. (688013.SH) announced that the company plans to distribute cash dividends of 10 shares per share for the first half of 2024...
Touchstone International Medical Science's (SHSE:688013) Profits May Not Reveal Underlying Issues
Tesson Healthcare 2024 Semi-Annual Report
Summary of Tesson Healthcare\'s 2024 Semi-Annual Report
touchstone international medical science co., ltd. (688013.SH): the net income in the first half of the year was 28.8513 million yuan, a year-on-year increase of 8.51%, and a proposed dividend of 10 yuan.
geleonhui August 28 | touchstone international medical science co., ltd. (688013.SH) announced its semi-annual report for 2024, with operating income of 0.133 billion yuan, a year-on-year increase of 4.11%; net income attributable to shareholders of the listed company 28.8513 million yuan, a year-on-year increase of 8.51%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses 25.8262 million yuan, a year-on-year increase of 21.24%; basic earnings per share 0.36 yuan. It is proposed to distribute a cash dividend of RMB 5.00 (including tax) to all shareholders for every 10 shares.
Touchstone International Medical Science Co., Ltd. (688013.SH): has repurchased 2.70% of the company's shares.
Touchstone International Medical Science Co., Ltd. (688013.SH) announced on August 2 that as of July 31, 2024, the company had repurchased a total of 2,193,413 shares, accounting for 2.70% of the total share capital. The highest repurchase price was 21.00 yuan/share, the lowest was 11.87 yuan/share, and the total amount paid was about RMB 37.5795 million (excluding transaction fees such as stamp duty and commission).
No Data
No Data